KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Other Non-Current Liabilities (2016 - 2025)

Humana (HUM) has disclosed Other Non-Current Liabilities for 16 consecutive years, with $2.4 billion as the latest value for Q3 2025.

  • On a quarterly basis, Other Non-Current Liabilities changed N/A to $2.4 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $2.4 billion, a N/A change, with the full-year FY2022 number at $1.5 billion, down 38.19% from a year prior.
  • Other Non-Current Liabilities was $2.4 billion for Q3 2025 at Humana, up from $2.3 billion in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $2.5 billion in Q3 2021 to a low of $1.5 billion in Q1 2023.
  • A 4-year average of $2.0 billion and a median of $2.0 billion in 2021 define the central range for Other Non-Current Liabilities.
  • Peak YoY movement for Other Non-Current Liabilities: surged 64.94% in 2021, then crashed 38.19% in 2022.
  • Humana's Other Non-Current Liabilities stood at $2.4 billion in 2021, then plummeted by 38.19% to $1.5 billion in 2022, then rose by 8.28% to $1.6 billion in 2023, then soared by 47.34% to $2.4 billion in 2025.
  • Per Business Quant, the three most recent readings for HUM's Other Non-Current Liabilities are $2.4 billion (Q3 2025), $2.3 billion (Q2 2025), and $2.3 billion (Q1 2025).